CYP3A4 plays a key role in the metabolism of important drugs used in breast cancer treatment which include anastrozole (5), letrozole (6), exemestane (7), tamoxifen (8), cyclophosphamide, paclitaxel and docetaxel (9, 10). This evidence concerns the gene CYP3A4 and breast cancer.